Primo Brands vs Constellation Brands
PRMB and STZ side by side, both in beverages. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PRMB and STZ compare
Constellation Brands is the larger company, worth 2.8 times as much as Primo Brands ($24.6B against $8.7B).
Primo Brands grew revenue faster over the last twelve months (4.5% versus −4.3% for Constellation Brands).
Constellation Brands keeps more of each dollar of sales as profit, with a net margin of 20.9% compared with 3.1% at Primo Brands.
Both pay dividends: Primo Brands yields 1.9% and Constellation Brands 2.1%.
Constellation Brands scores higher on the StockData Score (14 against 9 for Primo Brands), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PRMB | STZ |
|---|---|---|
| Size and price | ||
| Market cap | $8.7B | $24.6B |
| Share price | $23.88 | $145.61 |
| Change, 1 year | 48.5% | 11.7% |
| Change, 5 years | 28.6% | −38.1% |
| Beta (5Y) | 0.80 | 0.54 |
| Employees | 13K | 9,400 |
| StockData Score | ||
| Total score | 9 | 14 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 1 | 4 (better) |
| Health score | 1 | 2 (better) |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 42.6× | – |
| P/S | 1.3× (better) | 2.7× |
| P/B | 2.8× (better) | 2.9× |
| EV/EBITDA | 11.2× | 10.9× (better) |
| P/FCF | 20.9× | 13.4× (better) |
| FCF yield | 4.8% | 7.5% (better) |
| Fair value | $22.61 | $197.36 |
| Margin of safety | −5.6% | 26.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.5% (better) | −4.3% |
| Revenue growth, 5Y average | – | 1.2% |
| Net income growth (TTM) | – | 57.4% |
| Profitability | ||
| Gross margin | 29.4% | 52.7% (better) |
| Operating margin | 8.6% | 30.2% (better) |
| Net margin | 3.1% | 20.9% (better) |
| FCF margin | 6.1% | 20.0% (better) |
| Return on equity | 6.7% | 23.9% (better) |
| Return on invested capital | 5.1% | 12.3% (better) |
| Financial health | ||
| Debt / equity | 1.69 | 1.20 (better) |
| Net debt / EBITDA | 3.94 | 3.20 (better) |
| Interest coverage | 1.8× | 8.1× (better) |
| Current ratio | 1.11 (better) | 1.00 |
| Altman Z-score | 1.23 | 2.87 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.9% | 2.1% (better) |
| Payout ratio | 81.4% | 36.8% |
| Years of dividend growth | 1 | – |
| Buyback yield | 2.1% | 3.1% (better) |
| Shareholder yield | 4.1% | 5.3% (better) |
| Ownership | ||
| Held by institutions | 110% | 85.5% |
| Held by insiders | 59.9% | 16.3% |
| Insider net buying, 12 months | −$993M | −$1.1M (better) |
| Superinvestors holding | 2 (better) | 1 |
| Short interest, % of float | 20.2% | 6.3% |
Go deeper
- PRMB stock overview
- PRMB income statement
- PRMB valuation and score
- STZ stock overview
- STZ income statement
- STZ valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.